The effectiveness of interventions targeting spasticity on functional clinical outcomes in patients with multiple sclerosis: a systematic review of clinical trials

References

• Tullman MJ. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care. 2013;19(2):S15–S20.
   PubMed Web of Science ®Google Scholar
• Stokes M. Physical management in neurological rehabilitation. Amsterdam, Netherlands: Elsevier Health Sciences; 2004.
   Google Scholar
• Lance JW. The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology. 1980;30(12):1303–1313.
   PubMed Web of Science ®Google Scholar
• Barnes M, Kent R, Semlyen J, et al. Spasticity in multiple sclerosis. Neurorehabil Neural Repair. 2003;17(1):66–70.
   PubMed Web of Science ®Google Scholar
• Fox RJ, Rae-Grant AD, Béthoux F. Multiple sclerosis and related disorders: clinical guide to diagnosis, medical management, and rehabilitation. New York (NY): Springer Publishing Company; 2018.
   Google Scholar
• Beard S, Hunn A, Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technol Assess. 2003;7:1–111.
   Google Scholar
• Shakespeare D, Boggild M, Young CA. Anti‐spasticity agents for multiple sclerosis. Cochrane Database Syst Rev. 2003;(4):CD001332.
   PubMed Web of Science ®Google Scholar
• Amatya B, Khan F, La Mantia L, et al. Non pharmacological interventions for spasticity in multiple sclerosis. Cochrane Database Syst Rev. 2013;(2):CD009974.
   PubMed Web of Science ®Google Scholar
• de Sa JCC, Airas L, Bartholome E, et al. Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Ther Adv Neurol Disord. 2011;4(3):139–168.
   PubMedGoogle Scholar
• Etoom M, Khraiwesh Y, Lena F, et al. Effectiveness of physiotherapy interventions on spasticity in people with multiple sclerosis: a systematic review and meta-analysis. Am J Phys Med Rehabil. 2018;97(11):793–807.
   PubMed Web of Science ®Google Scholar
• Otero-Romero S, Sastre-Garriga J, Comi G, et al. Pharmacological management of spasticity in multiple sclerosis: systematic review and consensus paper. Mult Scler. 2016;22(11):1386–1396.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121–127.
   PubMed Web of Science ®Google Scholar
• Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192:540–542.
   PubMedGoogle Scholar
• Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67(2):206–207.
   PubMed Web of Science ®Google Scholar
• Ghotbi N, Ansari NN, Naghdi S, Hasson S, et al. Inter-rater reliability of the Modified Modified Ashworth Scale in assessing lower limb muscle spasticity. Brain Injury. 2009;23(10):815–819.
   PubMed Web of Science ®Google Scholar
• Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–148.
   PubMed Web of Science ®Google Scholar
• Rudick R, Antel J, Confavreux C, et al. Recommendations from the national multiple sclerosis society clinical outcomes assessment task force. Ann Neurol. 1997;42(3):379–382.
   PubMed Web of Science ®Google Scholar
• Wade D, Wood V, Heller A, et al. Walking after stroke. Measurement and recovery over the first 3 months. Scand J Rehabil Med. 1987;19(1):25–30.
   PubMedGoogle Scholar
• Shumway-Cook A, Gruber W, Baldwin M, et al. The effect of multidimensional exercises on balance, mobility, and fall risk in community-dwelling older adults. Phys Ther. 1997;77(1):46–57.
   PubMed Web of Science ®Google Scholar
• Lipkin D, Scriven A, Crake T, et al. Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed). 1986;292(6521):653–655.
   PubMedGoogle Scholar
• Tesio L, Perucca L, Paolo F. A short measure of balance in multiple sclerosis: validation. Funct Neurol. 1997;12(5):255–265.
   PubMed Web of Science ®Google Scholar
• Vickrey BG, Hays RD, Genovese BJ, et al. Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. J Clin Epidemiol. 1997;50(5):557–569.
   PubMed Web of Science ®Google Scholar
• Cioncoloni D, Taddei S, Bielli S, et al. Meaningful improvement in walking performance after Botulinum neurotoxin A (BoNT-A) in chronic spastic patients. NeuroRehabilitation. 2014;34(1):185–192.
   PubMed Web of Science ®Google Scholar
• Corey-Bloom J, Wolfson T, Gamst A, et al. Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. Can Med Assoc J. 2012;184(10):1143–1150.
   PubMed Web of Science ®Google Scholar
• Calabrò RS, Russo M, Naro A, et al. Robotic gait training in multiple sclerosis rehabilitation: can virtual reality make the difference? Findings from a randomized controlled trial. J Neurol Sci. 2017;377:25–30.
   PubMed Web of Science ®Google Scholar
• Eftekharsadat B, Babaei-Ghazani A, Mohammadzadeh M, et al. Effect of virtual reality-based balance training in multiple sclerosis. Neurol Res. 2015;37(6):539–544.
   PubMed Web of Science ®Google Scholar
• Kileff J, Ashburn A. A pilot study of the effect of aerobic exercise on people with moderate disability multiple sclerosis. Clin Rehabil. 2005;19(2):165–169.
   PubMed Web of Science ®Google Scholar
• Negahban H, Rezaie S, Goharpey S. Massage therapy and exercise therapy in patients with multiple sclerosis: a randomized controlled pilot study. Clin Rehabil. 2013;27(12):1126–1136.
   PubMed Web of Science ®Google Scholar
• Tarakci E, Yeldan I, Huseyinsinoglu BE, et al. Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial. Clin Rehabil. 2013;27(9):813–822.
   PubMed Web of Science ®Google Scholar
• Hugos CL, Bourdette D, Chen Y, et al. A group-delivered self-management program reduces spasticity in people with multiple sclerosis: a randomized, controlled pilot trial. Multip Scler J Exp Trans Clin. 2017;3(1):205521731769999.
   Google Scholar
• Schyns F, Paul L, Finlay K, et al. Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clin Rehabil. 2009;23(9):771–781.
   PubMed Web of Science ®Google Scholar
• Nilsagård Y, Denison E, Gunnarsson L-G. Evaluation of a single session with cooling garment for persons with multiple sclerosis–a randomized trial. Disabil Rehabil Technol. 2006;1(4):225–233.
   PubMedGoogle Scholar
• Higgins JP, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
   PubMed Web of Science ®Google Scholar
• Sosnoff JJ, Gappmaier E, Frame A, et al. Influence of spasticity on mobility and balance in persons with multiple sclerosis. J Neurol Phys Ther. 2011;35(3):129–132.
   PubMed Web of Science ®Google Scholar